U.S. And Europe Clinical Wearable Medical Devices Market Size, Share & Trends Analysis Report By Product, By Application, By Connectivity Type, By End Use, And Segment Forecasts, 2025

The U.S. and Europe clinical wearable medical devices market size was valued at USD 45.29 billion in 2024 and is expected to grow at a CAGR of 12.10% from 2025 to 2030. The increasing prevalence of chronic diseases like diabetes, heart disorders, and kidney disorders, along with advancements in clinical wearable medical devices, is expected to drive market growth. According to data from the American Heart Association, by June 2024, approximately 184 million individuals-over 61% of adults in the U.S.-are projected to be affected by some form of cardiovascular disorder by 2050. Such a high burden of chronic diseases is anticipated to drive the demand for clinical wearable medical devices in the coming years.

The rise in the prevalence of diabetes, driven by factors such as aging, obesity, and unhealthy lifestyles, is a significant contributor to market growth. This trend is increasing the demand for convenient and effective insulin delivery methods. In addition, the growing incidence of prediabetes is also fueling market expansion. For instance, according to data published by the CDC in May 2024, approximately 38 million people in the U.S. have diabetes, while about 98 million American adults are classified as pre-diabetic.

By 2030, the highest prevalence of diabetes is estimated to be in Spain, followed by Germany, with the second highest prevalence, while Norway will have the lowest prevalence. The increasing rates of diabetes in various European countries and the U.S. are expected to boost the demand for clinical wearable medical devices, such as connected insulin pumps and glucose monitoring systems.

Moreover, the increasing geriatric population is a significant factor driving the market for clinical wearable medical devices. Older adults are more vulnerable to chronic health conditions such as hypertension, heart disease, diabetes, and various pulmonary and neurological disorders. According to data published by the National Council on Aging, Inc. in May 2024, over 94% of individuals aged 60 and older have at least one chronic condition, while approximately 78% suffer from two or more such diseases.

In addition, people aged 65 and older are currently the fastest-growing segment of the U.S. population. The U.S. CDC's 2024 report projects that nearly a quarter of the population will be over 65 by 2060. Aging can weaken the immune system and increase susceptibility to various health issues, negatively impacting individuals' quality of life. Many in this age group are primarily dependent or semi-dependent, making frequent hospital visits challenging. Implementing effective strategies, such as the use of clinical wearable medical devices, can enhance the quality and longevity of life for older adults, promoting greater independence. As a result, the adoption of these devices is expected to rise among older individuals. They help them monitor key health indicators like blood pressure and respiratory rate, improving their overall health and quality of life.

U.S. And Europe Clinical Wearable Medical Devices Market Report Segmentation

This report forecasts revenue growth at regional and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the U.S. and Europe clinical wearable medical devices market report based on product, application, connectivity type, and end use:

Product Outlook (Revenue, USD Million, 2018 - 2030)
Insulin Pumps and Continuous Glucose Monitors (CGMs)
- Connected Insulin Pumps
- Continuous Glucose Monitoring Devices
Cardiac Monitors
- Portable ECG Monitors
- Cardiac Event Monitors
Respiratory Monitoring Devices
- Wearable Spirometers
- Connected Inhalers
Neurostimulators
- Wearable Vagus Nerve Stimulators (VNS)
- Wearable Deep Brain Stimulators (DBS)
Blood Pressure Monitors
- Ambulatory Blood Pressure Monitors
- Smart Blood Pressure Cuffs
Wearable Dialysis Devices
Wearable Oxygen Therapy Devices
Other Wearable Medical Devices
Application Outlook (Revenue, USD Million, 2018 - 2030)
Chronic Disease Management
- Diabetes
- Cardiovascular Disorders
- Respiratory Disorders
- Neurological Disorders
- Other Chronic Conditions
Post-operative Care
Remote Patient Monitoring (RPM)
Other Applications
Connectivity Type Outlook (Revenue, USD Million, 2018 - 2030)
Bluetooth-connected
Wi-Fi-enabled
Cellular-connected
IoT-based
End Use Outlook (Revenue, USD Million, 2018 - 2030)
Home Healthcare
Hospitals and Clinics
Ambulatory Care Settings
Other Settings

Product Code: GVR-4-68040-554-1

Chapter 1. Methodology and Scope

1.1. Market Segmentation and Scope
1.2. Research Methodology
1.3. Information Procurement
- 1.3.1. Purchased database
- 1.3.2. GVR's internal database
- 1.3.3. Secondary sources
- 1.3.4. Third Party Perspective
- 1.3.5. Primary research
- 1.3.6. Details of primary research
1.4. Information or Data Analysis
- 1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
- 1.6.1. Commodity flow analysis (Model 1)
  - 1.6.1.1. Approach 1: Commodity flow approach
- 1.6.2. Volume price analysis (Model 2)
  - 1.6.2.1. Approach 2: Volume price analysis
1.7. List of Data Sources
1.8. List of Primary Sources
1.9. List of Abbreviations

Chapter 2. Executive Summary

2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights

Chapter 3. U.S. and Europe Clinical Wearable Medical Devices Market Variables, Trends, & Scope

3.1. Market Lineage Outlook
- 3.1.1. Parent Market Outlook
- 3.1.2. Ancillary Market Outlook
3.2. Market Dynamics
- 3.2.1. Market Driver Analysis
  - 3.2.1.1. Rising prevalence of chronic diseases
  - 3.2.1.2. Increasing geriatric population
  - 3.2.1.3. Advent of technologically advanced products
- 3.2.2. Market Restraint Analysis
  - 3.2.2.1. High cost of devices and lack of reimbursement policies
  - 3.2.2.2. Product recalls
- 3.2.3. Market Opportunities Analysis
  - 3.2.3.1. Growing clinical trials
  - 3.2.3.2. Increasing demand for remote monitoring
  - 3.2.3.3. Rising focus on wearable artificial kidney devices
- 3.2.4. Market Challenge Analysis
  - 3.2.4.1. Accuracy and reliability
3.3. U.S. and Europe Clinical Wearable Medical Devices Market Analysis Tools
- 3.3.1. Industry Analysis - Porter's
  - 3.3.1.1. Bargaining power of suppliers
  - 3.3.1.2. Bargaining power of buyers
  - 3.3.1.3. Threat of substitutes
  - 3.3.1.4. Threat of new entrants
  - 3.3.1.5. Competitive rivalry
- 3.3.2. PESTEL Analysis
  - 3.3.2.1. Political & Legal Landscape
  - 3.3.2.2. Economic and Social Landscape
  - 3.3.2.3. Technological landscape

Chapter 4. U.S. and Europe Clinical Wearable Medical Devices Market: Product Estimates & Trend Analysis

4.1. Segment Dashboard
4.2. U.S. and Europe Clinical Wearable Medical Devices Market Movement Analysis
4.3. U.S. and Europe Clinical Wearable Medical Devices Market Size & Trend Analysis, by Product, 2018 to 2030 (USD Million)
4.4. Insulin Pumps and Continuous Glucose Monitors (CGMs)
- 4.4.1. Insulin Pumps and Continuous Glucose Monitors (CGMs) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.4.2. Connected Insulin Pumps
  - 4.4.2.1. Connected Insulin Pumps Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.4.3. Continuous Glucose Monitoring Devices
  - 4.4.3.1. Continuous Glucose Monitoring Devices Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.5. Cardiac Monitors
- 4.5.1. Cardiac Monitors Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.5.2. Portable ECG Monitors
  - 4.5.2.1. Portable ECG Monitors Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.5.3. Cardiac Event Monitors
  - 4.5.3.1. Cardiac Event Monitors Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.6. Respiratory Monitoring Devices
- 4.6.1. Respiratory Monitoring Devices Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.6.2. Wearable Spirometers
  - 4.6.2.1. Wearable Spirometers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.6.3. Connected Inhalers
  - 4.6.3.1. Connected Inhalers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.7. Neurostimulators
- 4.7.1. Neurostimulators Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.7.2. Wearable Vagus Nerve Stimulators (VNS)
  - 4.7.2.1. Wearable Vagus Nerve Stimulators (VNS) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.7.3. Wearable Deep Brain Stimulators (DBS)
  - 4.7.3.1. Wearable Deep Brain Stimulators (DBS) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.8. Blood Pressure Monitors
- 4.8.1. Blood Pressure Monitors Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.8.2. Ambulatory Blood Pressure Monitors
  - 4.8.2.1. Ambulatory Blood Pressure Monitors Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.8.3. Smart Blood Pressure Cuffs
  - 4.8.3.1. Smart Blood Pressure Cuffs Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.9. Wearable Dialysis Devices
- 4.9.1. Wearable Dialysis Devices Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.10. Wearable Oxygen Therapy Devices
- 4.10.1. Wearable Oxygen Therapy Devices Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.11. Other Wearable Medical Devices
- 4.11.1. Other Wearable Medical Devices Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. U.S. and Europe Clinical Wearable Medical Devices Market: Application Estimates & Trend Analysis

5.1. Segment Dashboard
5.2. U.S. and Europe Clinical Wearable Medical Devices Market Movement Analysis
5.3. U.S. and Europe Clinical Wearable Medical Devices Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
5.4. Chronic Disease Management
- 5.4.1. Chronic Disease Management Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 5.4.2. Diabetes
  - 5.4.2.1. Diabetes Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 5.4.3. Cardiovascular Disorders
  - 5.4.3.1. Cardiovascular Disorders Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 5.4.4. Respiratory Disorders
  - 5.4.4.1. Respiratory Disorders Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 5.4.5. Neurological Disorders
  - 5.4.5.1. Neurological Disorders Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 5.4.6. Other Chronic Conditions
  - 5.4.6.1. Other Chronic Conditions Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.5. Post-operative Care
- 5.5.1. Post-operative Care Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.6. Remote Patient Monitoring (RPM)
- 5.6.1. Remote Patient Monitoring (RPM) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.7. Other Applications
- 5.7.1. Other Applications Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. U.S. and Europe Clinical Wearable Medical Devices Market: Connectivity Type Estimates & Trend Analysis

6.1. Segment Dashboard
6.2. U.S. and Europe Clinical Wearable Medical Devices Market Movement Analysis
6.3. U.S. and Europe Clinical Wearable Medical Devices Market Size & Trend Analysis, by Connectivity Type, 2018 to 2030 (USD Million)
6.4. Bluetooth Connected
- 6.4.1. Bluetooth Connected Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5. Wi-Fi-enabled
- 6.5.1. Wi-Fi-enabled Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.6. Cellular-connected
- 6.6.1. Cellular-connected Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.7. IoT-based
- 6.7.1. IoT-based Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. U.S. and Europe Clinical Wearable Medical Devices Market: End Use Estimates & Trend Analysis

7.1. Segment Dashboard
7.2. U.S. and Europe Clinical Wearable Medical Devices Market Movement Analysis
7.3. U.S. and Europe Clinical Wearable Medical Devices Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
7.4. Home Healthcare
- 7.4.1. Home Healthcare Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5. Hospitals and Clinics
- 7.5.1. Hospitals and Clinics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6. Ambulatory Care Settings
- 7.6.1. Ambulatory Care Settings Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
7.7. Other Settings
- 7.7.1. Other Settings Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

8.1. Market Participant Categorization
8.2. Key Company Profiles
- 8.2.1. Medtronic
  - 8.2.1.1. Company Overview
  - 8.2.1.2. Financial Performance
  - 8.2.1.3. Product Benchmarking
  - 8.2.1.4. Strategic Initiatives
- 8.2.2. Abbott
  - 8.2.2.1. Company Overview
  - 8.2.2.2. Financial Performance
  - 8.2.2.3. Product Benchmarking
  - 8.2.2.4. Strategic Initiatives
- 8.2.3. Koninklijke Philips N.V.
  - 8.2.3.1. Company Overview
  - 8.2.3.2. Financial Performance
  - 8.2.3.3. Product Benchmarking
  - 8.2.3.4. Strategic Initiatives
- 8.2.4. GE HealthCare
  - 8.2.4.1. Company Overview
  - 8.2.4.2. Financial Performance
  - 8.2.4.3. Product Benchmarking
  - 8.2.4.4. Strategic Initiatives
- 8.2.5. OMRON Healthcare, Inc.
  - 8.2.5.1. Company Overview
  - 8.2.5.2. Financial Performance
  - 8.2.5.3. Product Benchmarking
  - 8.2.5.4. Strategic Initiatives
- 8.2.6. Dexcom, Inc.
  - 8.2.6.1. Company Overview
  - 8.2.6.2. Financial Performance
  - 8.2.6.3. Product Benchmarking
  - 8.2.6.4. Strategic Initiatives
- 8.2.7. Insulet Corporation
  - 8.2.7.1. Company Overview
  - 8.2.7.2. Financial Performance
  - 8.2.7.3. Product Benchmarking
  - 8.2.7.4. Strategic Initiatives
- 8.2.8. Tandem Diabetes Care, Inc.
  - 8.2.8.1. Company Overview
  - 8.2.8.2. Financial Performance
  - 8.2.8.3. Product Benchmarking
  - 8.2.8.4. Strategic Initiatives
- 8.2.9. Fresenius Medical Care AG
  - 8.2.9.1. Company Overview
  - 8.2.9.2. Financial Performance
  - 8.2.9.3. Product Benchmarking
  - 8.2.9.4. Strategic Initiatives
- 8.2.10. Inogen
  - 8.2.10.1. Company Overview
  - 8.2.10.2. Financial Performance
  - 8.2.10.3. Product Benchmarking
  - 8.2.10.4. Strategic Initiatives
- 8.2.11. Cognita Labs
  - 8.2.11.1. Company Overview
  - 8.2.11.2. Financial Performance
  - 8.2.11.3. Product Benchmarking
  - 8.2.11.4. Strategic Initiatives
- 8.2.12. AliveCor, Inc.
  - 8.2.12.1. Company Overview
  - 8.2.12.2. Financial Performance
  - 8.2.12.3. Product Benchmarking
  - 8.2.12.4. Strategic Initiatives
- 8.2.13. EMAY
  - 8.2.13.1. Company Overview
  - 8.2.13.2. Financial Performance
  - 8.2.13.3. Product Benchmarking
  - 8.2.13.4. Strategic Initiatives
- 8.2.14. VivaLNK, Inc.
  - 8.2.14.1. Company Overview
  - 8.2.14.2. Financial Performance
  - 8.2.14.3. Product Benchmarking
  - 8.2.14.4. Strategic Initiatives
- 8.2.15. CAIRE Inc
  - 8.2.15.1. Company Overview
  - 8.2.15.2. Financial Performance
  - 8.2.15.3. Product Benchmarking
  - 8.2.15.4. Strategic Initiatives
- 8.2.16. Ypsomed AG
  - 8.2.16.1. Company Overview
  - 8.2.16.2. Financial Performance
  - 8.2.16.3. Product Benchmarking
  - 8.2.16.4. Strategic Initiatives
- 8.2.17. Wellue
  - 8.2.17.1. Company Overview
  - 8.2.17.2. Financial Performance
  - 8.2.17.3. Product Benchmarking
  - 8.2.17.4. Strategic Initiatives
- 8.2.18. Qardio, Inc
  - 8.2.18.1. Company Overview
  - 8.2.18.2. Financial Performance
  - 8.2.18.3. Product Benchmarking
  - 8.2.18.4. Strategic Initiatives
- 8.2.19. Withings
  - 8.2.19.1. Company Overview
  - 8.2.19.2. Financial Performance
  - 8.2.19.3. Product Benchmarking
  - 8.2.19.4. Strategic Initiatives
- 8.2.20. iRhythm Technologies, Inc
  - 8.2.20.1. Company Overview
  - 8.2.20.2. Financial Performance
  - 8.2.20.3. Product Benchmarking
  - 8.2.20.4. Strategic Initiatives
- 8.2.21. OxyGo HQ Florida, LLC.
  - 8.2.21.1. Company Overview
  - 8.2.21.2. Financial Performance
  - 8.2.21.3. Product Benchmarking
  - 8.2.21.4. Strategic Initiatives
- 8.2.22. LOOKEETech
  - 8.2.22.1. Company Overview
  - 8.2.22.2. Financial Performance
  - 8.2.22.3. Product Benchmarking
  - 8.2.22.4. Strategic Initiatives
- 8.2.23. VitalConnect
  - 8.2.23.1. Company Overview
  - 8.2.23.2. Financial Performance
  - 8.2.23.3. Product Benchmarking
  - 8.2.23.4. Strategic Initiatives
- 8.2.24. Boston Scientific Corporation
  - 8.2.24.1. Company Overview
  - 8.2.24.2. Financial Performance
  - 8.2.24.3. Product Benchmarking
  - 8.2.24.4. Strategic Initiatives
- 8.2.25. Nexstim
  - 8.2.25.1. Company Overview
  - 8.2.25.2. Financial Performance
  - 8.2.25.3. Product Benchmarking
  - 8.2.25.4. Strategic Initiatives
- 8.2.26. LivaNova PLC
  - 8.2.26.1. Company Overview
  - 8.2.26.2. Financial Performance
  - 8.2.26.3. Product Benchmarking
  - 8.2.26.4. Strategic Initiatives
- 8.2.27. Neuropace Inc.
  - 8.2.27.1. Company Overview
  - 8.2.27.2. Financial Performance
  - 8.2.27.3. Product Benchmarking
  - 8.2.27.4. Strategic Initiatives
- 8.2.28. Nevro Corporation
  - 8.2.28.1. Company Overview
  - 8.2.28.2. Financial Performance
  - 8.2.28.3. Product Benchmarking
  - 8.2.28.4. Strategic Initiatives
- 8.2.29. electroCore, Inc.
  - 8.2.29.1. Company Overview
  - 8.2.29.2. Financial Performance
  - 8.2.29.3. Product Benchmarking
  - 8.2.29.4. Strategic Initiatives
- 8.2.30. tVNS Technologies GmbH
  - 8.2.30.1. Company Overview
  - 8.2.30.2. Financial Performance
  - 8.2.30.3. Product Benchmarking
  - 8.2.30.4. Strategic Initiatives
- 8.2.31. Laborie
  - 8.2.31.1. Company Overview
  - 8.2.31.2. Financial Performance
  - 8.2.31.3. Product Benchmarking
  - 8.2.31.4. Strategic Initiatives
- 8.2.32. Axonics, Inc
  - 8.2.32.1. Company Overview
  - 8.2.32.2. Financial Performance
  - 8.2.32.3. Product Benchmarking
  - 8.2.32.4. Strategic Initiatives

Product Code: GVR-4-68040-554-1

List of Tables

Table 1. List of Secondary Sources
Table 2. List of Abbreviations
Table 3. U.S. and Europe Clinical Wearable Medical Devices Market, by Product, 2018 - 2030 (USD Million)
Table 4. U.S. and Europe Clinical Wearable Medical Devices Market, by Application, 2018 - 2030 (USD Million)
Table 5. U.S. and Europe Clinical Wearable Medical Devices Market, by Connectivity Type, 2018 - 2030 (USD Million)
Table 6. U.S. and Europe Clinical Wearable Medical Devices Market, by End Use, 2018 - 2030 (USD Million)
Table 7. Participant's Overview
Table 8. Financial Performance
Table 9. Product Benchmarking
Table 10. Strategic Initiatives

List of Figures

Fig. 1 U.S. and Europe clinical wearable medical devices market segmentation
Fig. 2 Market research process
Fig. 3 Information procurement
Fig. 4 Primary research pattern
Fig. 5 Value chain-based size & forecasting
Fig. 6 Market formulation & validation
Fig. 7 Market snapshot (U.S. and Europe)
Fig. 8 Product type and application segment snapshot
Fig. 9 Connectivity type and end use segment snapshot
Fig. 10 Competitive landscape snapshot
Fig. 11 Global neuromodulation market and U.S. and Europe clinical wearable medical devices market value, 2024 (USD Billion)
Fig. 12 Market dynamics
Fig. 13 Number of Americans aged 65 or over from 2022 to 2050 (in Millions)
Fig. 14 Older population projection, UK from 2022 to 2072 (in Millions)
Fig. 15 Porter's five forces analysis
Fig. 16 PESTLE analysis
Fig. 17 U.S. and Europe clinical wearable medical devices market: Product outlook and key takeaways
Fig. 18 U.S. and Europe clinical wearable medical devices market: Product movement analysis
Fig. 19 Insulin pumps and Continuous Glucose Monitors (CGMs) market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 20 Connected insulin pumps market estimates and forecast, 2018 - 2030 USD Million
Fig. 21 Continuous glucose monitoring devices market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 22 Cardiac monitors market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 23 Portable ECG monitors market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 24 Cardiac event monitors market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 25 Respiratory monitoring devices market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 26 Wearable spirometers market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 27 Connected inhalers market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 28 Neurostimulators market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 29 Wearable vagus nerve stimulators (VNS) market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 30 Wearable deep brain stimulators (DBS) market estimates and forecast, 2018 - 2030 USD Million
Fig. 31 Blood pressure monitors market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 32 Ambulatory blood pressure monitors market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 33 Smart blood pressure cuffs market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 34 Wearable dialysis devices (portable dialysis machines) market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 35 Wearable oxygen therapy devices (portable oxygen concentrators market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 36 Other clinical wearable medical devices market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 37 U.S. and Europe clinical wearable medical devices market: Application outlook and key takeaways
Fig. 38 U.S. and Europe clinical wearable medical devices market: Application movement analysis
Fig. 39 Chronic disease management market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 40 Diabetes market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 41 Cardiovascular disorders market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 42 Respiratory disorders market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 43 Neurological disorders market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 44 Other chronic conditions market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 45 Post-operative market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 46 Remote patient monitoring market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 47 Other applications market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 48 U.S. and Europe clinical wearable medical devices market: Connectivity type outlook and key takeaways
Fig. 49 U.S. and Europe clinical wearable medical devices market: Connectivity type movement analysis
Fig. 50 Bluetooth connected market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 51 WI-FI-enabled market estimates and forecast, 2018 - 2030 (USD Million
Fig. 52 Cellular-connected market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 53 IoT-based market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 54 U.S. and Europe clinical wearable medical devices market: End use outlook and key takeaways
Fig. 55 U.S. and Europe clinical wearable medical devices market: End use movement analysis0
Fig. 56 Home healthcare market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 57 Hospitals and clinics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 58 Ambulatory care settings market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 59 Other settings (long term care settings, etc.) market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 60 U.S. and Europe clinical wearable medical devices market revenue by region, 2024 & 2030 (USD Million)
Fig. 61 Regional marketplace: Key takeaways
Fig. 62 Key country dynamics
Fig. 63 U.S. clinical wearable medical devices market, 2018 - 2030 (USD Million)
Fig. 64 Europe clinical wearable medical devices market, 2018 - 2030 (USD Million)
Fig. 65 Key country dynamics
Fig. 66 UK clinical wearable medical devices market, 2018 - 2030 (USD Million)
Fig. 67 Key country dynamics
Fig. 68 Germany clinical wearable medical devices market, 2018 - 2030 (USD Million)
Fig. 69 Key country dynamics
Fig. 70 France clinical wearable medical devices market, 2018 - 2030 (USD Million)
Fig. 71 Key country dynamics
Fig. 72 Italy clinical wearable medical devices market, 2018 - 2030 (USD Million)
Fig. 73 Key country dynamics
Fig. 74 Spain clinical wearable medical devices market, 2018 - 2030 (USD Million)
Fig. 75 Key country dynamics
Fig. 76 Sweden clinical wearable medical devices market, 2018 - 2030 (USD Million)
Fig. 77 Key country dynamics
Fig. 78 Denmark clinical wearable medical devices market, 2018 - 2030 (USD Million)
Fig. 79 Key country dynamics
Fig. 80 Norway clinical wearable medical devices market, 2018 - 2030 (USD Million)
Fig. 81 Key company categorization
Fig. 82 U.S. and Europe clinical wearable medical devices market share analysis, 2024, neurostimulators
Fig. 83 U.S. and Europe clinical wearable medical devices market share analysis, 2024, Continuous Glucose Monitors (CGMs)
Fig. 84 U.S. and Europe clinical wearable medical devices market share analysis, 2024, connected insulin pumps
Fig. 85 U.S. and Europe clinical wearable medical devices market share analysis, 2024, blood pressure monitors
Fig. 86 U.S. and Europe clinical wearable medical devices market share analysis, 2024, oxygen concentrators
Fig. 87 U.S. and Europe clinical wearable medical devices market share analysis, 2024, wearable dialysis devices (portable dialysis machines)
Fig. 88 Strategic framework

U.S. And Europe Clinical Wearable Medical Devices Market Size, Share & Trends Analysis Report By Product, By Application, By Connectivity Type, By End Use, And Segment Forecasts, 2025 - 2030

Description

Table of Contents

List of Tables

Market Size & Trends:

Table of Contents

Chapter 1. Methodology and Scope

Chapter 2. Executive Summary

Chapter 3. U.S. and Europe Clinical Wearable Medical Devices Market Variables, Trends, & Scope

Chapter 4. U.S. and Europe Clinical Wearable Medical Devices Market: Product Estimates & Trend Analysis

Chapter 5. U.S. and Europe Clinical Wearable Medical Devices Market: Application Estimates & Trend Analysis

Chapter 6. U.S. and Europe Clinical Wearable Medical Devices Market: Connectivity Type Estimates & Trend Analysis

Chapter 7. U.S. and Europe Clinical Wearable Medical Devices Market: End Use Estimates & Trend Analysis

Chapter 8. Competitive Landscape

List of Tables

List of Figures